Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

But a lot of work remains to get eligible people screened for lung cancer and expand affordable access to the targeted ...

Last year, Coskun and his team introduced a new study in “single cell spatial metabolomics,” which explores the distribution ...

More than 5,000 people in England have now been diagnosed with cancer through the NHS Targeted Lung Health Check programme.

Since its launch in 2019, the NHS Targeted Lung Health Check Programme has already saved more than 5,000 lives by catching ...

There are many sub-types of NSCLC, but the three main ones are adenocarcinoma, squamous cell carcinoma and large cell ...

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.

ADCs, including the widely used cancer drug Enhertu (trastuzumab deruxtecan), represent a new wave of targeted therapies.

The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, presented data at the International Oncolytic Virotherapy ...

Current and past smokers, aged 55 to 74, are being asked about their lung health, with CT scans for those at risk of lung ...